Mechanisms of neurodegeneration in Huntington’s disease
- 28 June 2008
- journal article
- review article
- Published by Wiley in European Journal of Neuroscience
- Vol. 27 (11), 2803-2820
- https://doi.org/10.1111/j.1460-9568.2008.06310.x
Abstract
Huntington's disease (HD) is caused by an expansion of cytosine2013adenine2013guanine (CAG) repeats in the huntingtin gene, which leads to neuronal loss in the striatum and cortex and to the appearance of neuronal intranuclear inclusions of mutant huntingtin. Huntingtin plays a role in protein trafficking, vesicle transport, postsynaptic signaling, transcriptional regulation, and apoptosis. Thus, a loss of function of the normal protein and a toxic gain of function of the mutant huntingtin contribute to the disruption of multiple intracellular pathways. Furthermore, excitotoxicity, dopamine toxicity, metabolic impairment, mitochondrial dysfunction, oxidative stress, apoptosis, and autophagy have been implicated in the progressive degeneration observed in HD. Nevertheless, despite the efforts of a multidisciplinary scientific community, there is no cure for this devastating neurodegenerative disorder. This review presents an overview of the mechanisms that may contribute for HD pathogenesis. Ultimately, a better understanding of these mechanisms will lead to the development of more effective therapeutic targets.http://dx.doi.org/10.1111/j.1460-9568.2008.06310.Keywords
This publication has 102 references indexed in Scilit:
- Normal platelet mitochondrial complex I activity in Huntington’s DiseaseNeurobiology of Disease, 2007
- Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington’s diseaseNeuroscience, 2007
- Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patientsBiochemical and Biophysical Research Communications, 2007
- Lysosomal proteases are involved in generation of N-terminal huntingtin fragmentsNeurobiology of Disease, 2006
- FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical culturesNeurobiology of Disease, 2004
- NR2A and NR2B receptor gene variations modify age at onset in Huntington diseaseneurogenetics, 2004
- Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical studyJournal of Chemical Neuroanatomy, 2004
- CAG mutation effect on rate of progression in Huntington's diseaseNeurological Sciences, 2002
- The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitryBrain Research Reviews, 1997
- Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatumNeuroscience Letters, 1986